Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva Maintenance After Chemo-Radiotherapy in Unresectable NSCLC
NCT00466284Phase 2Unknown
- Sponsor
- Grupo Gallego de Cáncer de Pulmón
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Grupo Gallego de Cáncer de Pulmón. Status: unknown.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00466284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466284.